Evidence map›Paper›PMID 40942054›Full record

ArticleMolecules (Basel, Switzerland)2025

Optimization of the Chitosan-Assisted Extraction for Phillyrin and Forsythoside A from

Teng Wang, Zexi Zhang, Jiayu Wang, Yuanyuan Fu, Xiaolin Zou, Wei Li, Zhaolun Zhang, Youting Liu, Zhaojun Jia, Zhenguo Wen and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Teng WangDepartment of Pharmaceutics, Beijing Institute of Petrochemical Technology, Beijing 102627, China.ORCID 0009-0001-0144-3941
Zexi ZhangDepartment of Pharmaceutics, Beijing Institute of Petrochemical Technology, Beijing 102627, China.
Jiayu WangDepartment of Pharmaceutics, Beijing Institute of Petrochemical Technology, Beijing 102627, China.
Yuanyuan FuBeijing Uproven Medical Technology Co., Ltd., Beijing 102600, China.
Xiaolin ZouDepartment of Pharmaceutics, Beijing Institute of Petrochemical Technology, Beijing 102627, China.
Wei LiDepartment of Pharmaceutics, Beijing Institute of Petrochemical Technology, Beijing 102627, China.
Zhaolun ZhangBeijing Uproven Medical Technology Co., Ltd., Beijing 102600, China.
Youting LiuBeijing Uproven Institute of Dermatology, Beijing 102600, China.
Zhaojun JiaDepartment of Pharmaceutics, Beijing Institute of Petrochemical Technology, Beijing 102627, China.
Zhenguo WenDepartment of Pharmaceutics, Beijing Institute of Petrochemical Technology, Beijing 102627, China.ORCID 0009-0006-4375-8462
Yong ChenBeijing Uproven Institute of Dermatology, Beijing 102600, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, a green and efficient extraction methodology was developed by leveraging the unique properties of chitosan-namely its non-toxicity, biocompatibility, and adhesive nature-to enhance the recovery of bioactive ingredients from

Indexed as

ChitosanForsythiaGlucosidesGlycosidesPlant ExtractsPlant LeavesMolecular Docking SimulationSpectroscopy, Fourier Transform InfraredX-Ray DiffractionChitosanforsythiasideGlucosidesGlycosidesphillyrinPlant ExtractschitosanForsythia suspensa leavesresponse surface methodology

Identifiers

PMID40942054
PMCPMC12430607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.